Leverett, MA, United States of America

Samuel Black

This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel Black. Retrieved from https://idiyas.com/inventor/samuel-black

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Samuel Black in Recombinant Gas Vesicles

Introduction

Samuel Black is an accomplished inventor based in Leverett, MA (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work on recombinant gas vesicles. His research focuses on developing compositions that can elicit specific immune responses, which has important implications for vaccine development and therapeutic applications.

Latest Patents

Samuel Black holds a patent for his invention titled "Recombinant gas vesicles and uses thereof." This patent features a composition that includes substantially pure recombinant gas vesicles, which have at least one heterologous peptide inserted into one of their structural proteins. When administered to a mammal, these recombinant gas vesicles are capable of eliciting antibodies that specifically bind to the heterologous peptide. The heterologous peptide can be any peptide against which one wishes to raise antibodies, such as a peptide found in the gp120 protein of the human immunodeficiency virus (HIV). This innovative approach has the potential to enhance vaccine efficacy and improve immune responses.

Career Highlights

Samuel Black is affiliated with the University of Massachusetts, where he conducts his research and development activities. His work has garnered attention for its potential applications in immunology and vaccine development. With a focus on recombinant technologies, he continues to explore new avenues for enhancing immune responses through innovative compositions.

Collaborations

Samuel collaborates with notable colleagues, including Fazeela Morshed and Elizabeth S. Stuart. These collaborations foster a dynamic research environment that encourages the exchange of ideas and expertise, ultimately leading to advancements in their respective fields.

Conclusion

Samuel Black's contributions to the field of biotechnology, particularly through his patent on recombinant gas vesicles, highlight his innovative spirit and dedication to advancing medical science. His work has the potential to significantly impact vaccine development and therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…